Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Erratum for Grossman et al., target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic.

Grossman TH, Starosta AL, Fyfe C, O'Brien W, Rothstein DM, Mikolajka A, Wilson DN, Sutcliffe JA.

Antimicrob Agents Chemother. 2015 Sep;59(9):5870. doi: 10.1128/AAC.01551-15. No abstract available.

2.

Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis.

Jenner L, Starosta AL, Terry DS, Mikolajka A, Filonava L, Yusupov M, Blanchard SC, Wilson DN, Yusupova G.

Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3812-6. doi: 10.1073/pnas.1216691110. Epub 2013 Feb 19.

3.

Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic.

Grossman TH, Starosta AL, Fyfe C, O'Brien W, Rothstein DM, Mikolajka A, Wilson DN, Sutcliffe JA.

Antimicrob Agents Chemother. 2012 May;56(5):2559-64. doi: 10.1128/AAC.06187-11. Epub 2012 Feb 21. Erratum in: Antimicrob Agents Chemother. 2015 Sep;59(9):5870.

4.

Differential effects of thiopeptide and orthosomycin antibiotics on translational GTPases.

Mikolajka A, Liu H, Chen Y, Starosta AL, Márquez V, Ivanova M, Cooperman BS, Wilson DN.

Chem Biol. 2011 May 27;18(5):589-600. doi: 10.1016/j.chembiol.2011.03.010.

5.

Proteomic characterization of archaeal ribosomes reveals the presence of novel archaeal-specific ribosomal proteins.

Márquez V, Fröhlich T, Armache JP, Sohmen D, Dönhöfer A, Mikolajka A, Berninghausen O, Thomm M, Beckmann R, Arnold GJ, Wilson DN.

J Mol Biol. 2011 Feb 4;405(5):1215-32. doi: 10.1016/j.jmb.2010.11.055. Epub 2010 Dec 4.

PMID:
21134383
6.

Head swivel on the ribosome facilitates translocation by means of intra-subunit tRNA hybrid sites.

Ratje AH, Loerke J, Mikolajka A, Brünner M, Hildebrand PW, Starosta AL, Dönhöfer A, Connell SR, Fucini P, Mielke T, Whitford PC, Onuchic JN, Yu Y, Sanbonmatsu KY, Hartmann RK, Penczek PA, Wilson DN, Spahn CM.

Nature. 2010 Dec 2;468(7324):713-6. doi: 10.1038/nature09547.

7.

Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition.

Starosta AL, Karpenko VV, Shishkina AV, Mikolajka A, Sumbatyan NV, Schluenzen F, Korshunova GA, Bogdanov AA, Wilson DN.

Chem Biol. 2010 May 28;17(5):504-14. doi: 10.1016/j.chembiol.2010.04.008.

8.

Identification of distinct thiopeptide-antibiotic precursor lead compounds using translation machinery assays.

Starosta AL, Qin H, Mikolajka A, Leung GY, Schwinghammer K, Nicolaou KC, Chen DY, Cooperman BS, Wilson DN.

Chem Biol. 2009 Oct 30;16(10):1087-96. doi: 10.1016/j.chembiol.2009.09.016.

9.

Protein solubility: sequence based prediction and experimental verification.

Smialowski P, Martin-Galiano AJ, Mikolajka A, Girschick T, Holak TA, Frishman D.

Bioinformatics. 2007 Oct 1;23(19):2536-42. Epub 2006 Dec 6.

PMID:
17150993
10.

Structure of the N-terminal domain of the FOP (FGFR1OP) protein and implications for its dimerization and centrosomal localization.

Mikolajka A, Yan X, Popowicz GM, Smialowski P, Nigg EA, Holak TA.

J Mol Biol. 2006 Jun 16;359(4):863-75. Epub 2006 Apr 24.

PMID:
16690081
11.

Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences.

Singh M, Krajewski M, Mikolajka A, Holak TA.

J Biol Chem. 2005 Nov 11;280(45):37868-76. Epub 2005 Aug 23.

12.

NMR and mass spectrometry studies of putative interactions of cell cycle proteins pRb and CDK6 with cell differentiation proteins MyoD and ID-2.

Smialowski P, Singh M, Mikolajka A, Majumdar S, Joy JK, Nalabothula N, Krajewski M, Degenkolbe R, Bernard HU, Holak TA.

Biochim Biophys Acta. 2005 Jun 15;1750(1):48-60. Epub 2005 Apr 14.

PMID:
15878699

Supplemental Content

Loading ...
Support Center